Inflammatory inclusion body myositis (Q41416): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A miosite por corpos de inclusão (MCI) é a miopatia inflamatória idiopática mais comum após os 50 anos de idade. Apresenta-se, tipicamente, com fraqueza muscular assimétrica, insidiosa e crônica, proximal de pernas e/ou distal em braços, levando a quedas recorrentes e perda de destreza. A creatinofosfoquinase (CPK) está aumentada em até 15 vezes na MCI e a eletroneuromiografia por agulha mostra principalmente uma miopatia irritativa crônica. A histopatologia do músculo demonstra exsudatos inflamatórios no endomísio circundando e invadindo as fibras musculares não necróticas, muitas vezes acompanhados de vacúolos marginados e depósitos de proteínas. Apesar da histopatologia muscular inflamatória, é provável que a MCI tenha um componente degenerativo proeminente, suportado pela refratariedade à terapia imunossupressora.
description / endescription / en
 
Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy after age 50. It typically presents with chronic insidious proximal leg and/or distal arm asymmetric muscle weakness leading to recurrent falls and loss of dexterity. Creatine kinase is up to 15 times elevated in IBM and needle electromyography mostly shows a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibres often times accompanied by rimmed vacuoles and protein deposits. Despite inflammatory muscle pathology, it is likely that IBM has a prominent degenerative component as supported by refractoriness to immunosuppressive therapy.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/797555186 / rank
 
Normal rank
Property / CURIE
 
CID11:4A41.20
Property / CURIE: CID11:4A41.20 / rank
 
Normal rank
Property / Canary Token
 
dki-india-4A41.20
Property / Canary Token: dki-india-4A41.20 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: G72.4 / rank
 
Normal rank

Latest revision as of 07:34, 13 August 2026

Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy after age 50. It typically presents with chronic insidious proximal leg and/or distal arm asymmetric muscle weakness leading to recurrent falls and loss of dexterity. Creatine kinase is up to 15 times elevated in IBM and needle electromyography mostly shows a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibres often times accompanied by rimmed vacuoles and protein deposits. Despite inflammatory muscle pathology, it is likely that IBM has a prominent degenerative component as supported by refractoriness to immunosuppressive therapy.
Language Label Description Also known as
default for all languages
4A41.20
    English
    Inflammatory inclusion body myositis
    Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy after age 50. It typically presents with chronic insidious proximal leg and/or distal arm asymmetric muscle weakness leading to recurrent falls and loss of dexterity. Creatine kinase is up to 15 times elevated in IBM and needle electromyography mostly shows a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibres often times accompanied by rimmed vacuoles and protein deposits. Despite inflammatory muscle pathology, it is likely that IBM has a prominent degenerative component as supported by refractoriness to immunosuppressive therapy.

      Statements

      CID11:4A41.20
      0 references
      dki-india-4A41.20
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references